Skip to main content
Google Tag Manager
Careers
Patient Portal
Payment Portal
Provider Portal
Toggle navigation
Menu
Products
Horizon
Advanced carrier screening
Spectrum
Preimplantation genetics
Panorama
Next-generation NIPT
Vistara
Single-gene NIPT
Anora
Miscarriage test (POC)
Evercord
Newborn stem cell banking
Signatera
Molecular monitoring (MRD)
Prospera
Transplant assessment
Constellation
Technology licensing
X
About Natera
Our Company
Our People
Our Community
Science & Informatics
Careers
For Reproductive Testing
Horizon Carrier Screen
Spectrum PGT
Panorama Prenatal Test
Vistara
Anora Miscarriage Test
For Cord Blood Banking
Evercord
Pricing
For Oncology
Signatera
For Organ Transplant
Prospera
For Laboratories
Constellation
Patient Portal
Provider Portal
Resources
Webinars
Test Cost Estimator
Find Clinical Specialist
Talk to a Genetic Counselor
Media
Investor Relations
Contact Us
Your Questions Answered.
Your Questions Answered.
Your Questions Answered.
Your Questions Answered.
Press Releases
Media Buzz
Media Assets
Media Inquiries
Press Releases
Press Release Year
Year
-Year
2016
2017
2018
2019
2020
Search
Date
Title
01/09/20
Natera Statement Regarding CareDx Suit
01/09/20
Natera Launches BESPOKE CRC Study to Evaluate Outcomes in 1,000 Signatera™ Patients with Stage II-III Colorectal Cancer
01/08/20
Natera To Webcast Live Presentation at the 38th Annual J.P. Morgan Healthcare Conference
01/06/20
Natera Announces Achievement of $55 Million In Pharma Contracts and Issuance of New Oncology Patents
Back to Top
